The Growing Importance of Direct-to-Consumer Payments in Clinical Trials

Driven by game-changing innovations and medical advancements over the past few decades, the pharmaceutical industry has seen enormous growth. This has involved significant global expansion as companies have grown organically around the world, as well as through strategic acquisitions. Such industry-wide growth has put tremendous pressure on Treasury organizations to transform in order to meet the evolving needs of the business and the shifting demands of the marketplace.

In this article we discuss:

• Treasury’s emerging role in supporting clinical trials
• Digital clinical trial payout facilitation
• Cross-border payments in global clinical trials
• How Treasury supports drug development success

As pharmaceutical companies continue to make major advancements in disease prevention and treatment, Treasury will continue to play a significant role in supporting success of the business.

Read the full report  here.